President & Representative Director
Shire Japan KK
Dr. Glen Sunohara is a pharmaceutical executive with a wealth of global and in-market experience. He currently serves as the JAPAC Regional Head for Shire Pharmaceuticals and the President and Representative Director of Shire Japan KK. Before joining Shire, Glen was the Operating Officer and Head of Marketing at Nippon Boehringer Ingelheim, also based in Japan, where he has improved the talent and capabilities of the marketing organization and led "Best in World" launches of multiple new brands including Januvia, Cosopt and Bridion. Previously, Glen held various senior management roles at Novartis. He began his career as a Sales Representative at Novartis Canada and quickly worked his way up through the company ranks, ultimately serving as the Head of Marketing for Novartis Japan. Glen is continuously experimenting especially in the areas of insight driven consumer marketing, exploring alternative channel strategies and looking for innovative new business models. He holds a PhD from the University of Toronto and completed a post-doctoral fellowship at the Clarke Institute of Psychiatry, where he studied the molecular genetics of Attention Deficit Hyperactivity Disorder (ADHD). Glen also serves as chairperson for Marketing Excellence Japan.